In addition to the upregulation of CB1R, multiple studies demonstrated that overactivity of iNOS in the lungs contributes to PF, suggesting that iNOS inhibition can provide therapeutic benefit (26–29). This evidence concerns the gene CNR1 and pemphigus foliaceus.